Your sanctions team just received notice of the July 20, 2026 State Department action against Sudan under the Chemical and Biological Weapons Control and Warfare Elimination Act. Now you're facing a decision: do you immediately halt all Sudan-related activity, maintain operations under available waivers, or exit gradually while managing existing exposures?
This isn't a simple compliance checkbox. The decision depends on your institution's risk appetite, operational footprint, and ability to manage nuanced licensing requirements.
The Decision You're Facing
You need to determine how aggressively to respond to Section 307(b) sanctions that impose financial institution opposition requirements and sweeping export controls. Your choice affects customer relationships, subsidiary operations, and your institution's sanctions violation risk profile.
Three factors matter most: whether you provide financial services that touch international financial institutions, whether you facilitate export financing or trade finance, and whether you have subsidiaries or correspondent relationships that involve Sudan or Sudanese nationals.
Key Factors That Affect Your Choice
Your institution's role in international financing. If you participate in loan syndications, development finance, or multilateral lending that could route through institutions covered under Section 701 of the International Financial Institutions Act, you're directly affected. The US will oppose any loan or financial or technical assistance to Sudan through these channels. You can't simply process the transaction and claim you didn't know about the opposition requirement.
Your export finance and trade finance exposure. The new measures prohibit exports of essentially all goods and technology on the Commerce Control List to Sudan, with specific License Exception carve-outs. If you provide letters of credit, supply chain financing, or documentary collections for Sudan-related trade, you need to verify that each transaction falls under an allowed exception or has appropriate licensing. "Presumption of denial" licensing policy means you can't assume approvals will come through on normal timelines.
Your subsidiary structure and ownership stakes. The waiver for US wholly-owned subsidiaries and foreign subsidiaries operating in Sudan creates a compliance trap. You can continue certain operations, but only for items that were licensable under pre-notice policy and only with proper documentation. This requires legal review of each subsidiary's activity, not a blanket continuation assumption.
Path A: Freezing Without Delay and Exit Planning
Choose this path if your institution has low Sudan exposure, high regulatory scrutiny from other matters, or limited capacity to administer complex waiver compliance.
When this makes sense: You operate primarily in US markets, your Sudan business represents less than 1% of revenue in affected product lines, and you've previously faced sanctions penalties or consent orders. The reputational and operational cost of maintaining nuanced Sudan compliance outweighs the business value.
How to execute: Issue an immediate internal prohibition on new Sudan transactions. Notify affected customers within 48 hours that you're exiting Sudan business. For existing commitments, determine which qualify as grandfathered under the "authorized before publication" provision for deemed exports. Everything else gets a 90-day wind-down timeline with documented legal review at each step.
What you'll need: A cross-functional team including sanctions analysts, trade finance specialists, and subsidiary general counsels. Document every exit decision with specific reference to Section 307(b) requirements. Don't just say "Sudan sanctions" in your case notes; cite the specific prohibition that applies.
The compliance advantage: You eliminate ongoing monitoring burden and remove exposure to the "presumption of denial" licensing uncertainty. If Sudan meets the Act's conditions in future and sanctions lift, you can re-enter from a clean baseline.
Path B: Selective Continuation Under Waivers
Choose this path if you have significant Sudan operations, specialized expertise in License Exception compliance, or subsidiary operations that qualify for continued activity.
When this makes sense: You're a multinational bank with established Sudan subsidiaries, you have trade finance specialists who regularly work with Commerce Control List classifications, or you serve customers in aviation safety or other specifically waived categories. Your compliance team has demonstrated capability in managing complex sanctions carve-outs.
How to execute: Immediately classify all Sudan exposure into three buckets: (1) items not on the CCL that can continue, (2) transactions qualifying for specified License Exceptions (CCD, GOV, ENC, BAG, TMP, RPL, TSU, ACE per 15 CFR part 740), and (3) everything else that requires licensing under presumption of denial. Halt bucket three immediately. For bucket two, implement enhanced transaction-by-transaction screening that verifies License Exception criteria before processing.
What you'll need: Access to current CCL classifications, legal counsel familiar with Export Administration Act licensing, and enhanced name screening that flags Sudanese nationals even when the transaction doesn't originate in Sudan. The notice specifically extends prohibitions to Sudanese nationals, not just Sudan-located parties.
The compliance risk: You're maintaining operations in a "presumption of denial" environment. Every licensing decision takes longer, and approval isn't guaranteed. You need documented evidence that you verified waiver applicability for each transaction. If your trade finance team processes a letter of credit for CCL goods without confirming License Exception coverage, you've violated Section 6 of the Export Administration Act.
Path C: Hybrid Approach With Subsidiary Segregation
Choose this path if you have wholly-owned or foreign subsidiaries in Sudan that generate significant revenue, but your US operations have minimal Sudan exposure.
When this makes sense: Your subsidiary operations were established before the notice, they deal primarily in goods and technology that were licensable under prior policy, and you can implement operational segregation between subsidiary activity and US parent operations.
How to execute: Prohibit all new Sudan business at the US parent level and US-controlled entities. For qualifying subsidiaries, obtain legal opinions confirming that their current product lines fall within the subsidiary waiver. Implement strict information barriers so that US-based staff don't participate in Sudan transaction decisions or approvals. Require subsidiaries to obtain their own export licenses where applicable, rather than relying on parent company authorizations.
What you'll need: Separate compliance reporting for subsidiary Sudan activity, independent legal review of subsidiary product classifications, and documented policies proving that US personnel don't direct or control Sudan transactions. The waiver protects subsidiary operations, but only if they're genuinely independent in their Sudan dealings.
The structural challenge: You're operating a split compliance framework. Your US operations follow Path A (Freezing Without Delay), while subsidiaries follow Path B (selective continuation). This requires clear internal communication so that relationship managers don't inadvertently route Sudan business to the wrong entity.
Summary Matrix
| Factor | Path A: Exit | Path B: Continue Under Waivers | Path C: Subsidiary Segregation |
|---|---|---|---|
| Best for | Minimal Sudan exposure, recent sanctions issues | Established Sudan operations, strong export compliance capability | Significant subsidiary presence, ability to segregate operations |
| Timeline | 90-day wind-down | Ongoing with enhanced monitoring | Immediate US freeze, subsidiary continuation |
| Compliance burden | Low after exit complete | High; requires transaction-level License Exception verification | Medium; requires operational segregation and dual frameworks |
| Key requirement | Documented exit decisions citing specific Section 307(b) prohibitions | Current CCL access and Export Administration Act expertise | Legal opinions on subsidiary waiver applicability and information barriers |
| Primary risk | Customer relationship damage during exit | License denial under "presumption of denial" policy | Inadvertent US involvement in subsidiary Sudan transactions |
The State Department notice specifies these measures remain in place for at least one year. That's your minimum compliance horizon. Don't choose a path based on hoping for quick sanctions relief. Choose based on your institution's actual capability to manage the compliance requirements you're selecting.
